Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT04715269

Role of Alprazolam in the Management of Acute Coronary Syndrome (A-ACS-PK)

Effect of Alprazolam on Heart Rate and Acute Inflammatory Marker in Acute Coronary Syndrome Patients

Sponsor: Sohaib Ashraf

Conditions Acute Coronary Syndrome Anxiety Heart Diseases Myocardial Infarction ST Elevation Myocardial Infarction

Updated 4 times since 2021 Last updated: Jan 19, 2021 Started: Dec 25, 2020 Primary completion: Nov 15, 2021 Completion: Feb 20, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Acute Coronary Syndrome and Anxiety, this trial is ongoing. The trial is conducted by Sohaib Ashraf and has accumulated 4 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Feb 2023 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status
Feb 2021 — Feb 2023 [monthly]

Recruiting PHASE1_PHASE2

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sohaib Ashraf

Data source: Sheikh Zayed Federal Postgraduate Medical Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lahore, Pakistan